Shibata Rei, Izumiya Yasuhiro, Sato Kaori, Papanicolaou Kyriakos, Kihara Shinji, Colucci Wilson S, Sam Flora, Ouchi Noriyuki, Walsh Kenneth
Molecular Cardiology/Whitaker Cardiovascular Institute, Boston University School of Medicine, 715 Albany Street, W611, Boston, MA 02118, USA.
J Mol Cell Cardiol. 2007 Jun;42(6):1065-74. doi: 10.1016/j.yjmcc.2007.03.808. Epub 2007 Mar 20.
There is an association between obesity and heart failure associated with LV dysfunction. Adiponectin is an adipocyte-derived hormone that is downregulated in obesity. Here, we examined the role of adiponectin in cardiac remodeling after myocardial infarction with loss- and gain-of-function genetic manipulations in an experimental model. Myocardial infarction was created in adiponectin-deficient (APN-KO) and wild-type (WT) mice by the permanent ligation of the left anterior descending (LAD) artery. For some experiments, adenoviral vectors expressing adiponectin or beta-galactosidase were delivered systemically. Cardiac structure and function were assessed by echocardiographic and Millar catheter measurements. Myocardial capillary density was assessed by staining with anti-CD31 antibody. Myocyte apoptotic activity was determined by TUNEL-staining. Myocardial interstitial fibrosis was evaluated by Masson's trichrome staining. APN-KO mice showed exacerbated left ventricular (LV) dilation, myocyte hypertrophy and contractile dysfunction compared with WT mice at 4 weeks after LAD ligation. Impaired LV function in APN-KO mice was coupled to myocyte hypertrophy, increased apoptotic activity and interstitial fibrosis in the remote zone, and reduced capillary density in the infarct border zone. No difference in infarct size was observed between WT and APN-KO mice. Administration of adenovirus-mediated adiponectin in WT mice resulted in decreased LV dilatation and improved LV function that was associated with increased capillary density in the infarct border zone and decreased myocyte hypertrophy, diminished myocardial apoptosis and decreased interstitial fibrosis in the remote zone. These data suggest that adiponectin protects against the development of systolic dysfunction after myocardial infarction through its abilities to suppress cardiac hypertrophy and interstitial fibrosis, and protect against myocyte and capillary loss.
肥胖与伴有左心室功能障碍的心力衰竭之间存在关联。脂联素是一种由脂肪细胞分泌的激素,在肥胖状态下其表达下调。在此,我们通过在实验模型中进行功能缺失和功能获得的基因操作,研究了脂联素在心肌梗死后心脏重塑中的作用。通过永久性结扎左前降支(LAD)动脉,在脂联素缺乏(APN-KO)小鼠和野生型(WT)小鼠中制造心肌梗死。对于一些实验,系统性地给予表达脂联素或β-半乳糖苷酶的腺病毒载体。通过超声心动图和Millar导管测量评估心脏结构和功能。用抗CD31抗体染色评估心肌毛细血管密度。通过TUNEL染色测定心肌细胞凋亡活性。用Masson三色染色评估心肌间质纤维化。与LAD结扎后4周的WT小鼠相比,APN-KO小鼠表现出更严重的左心室(LV)扩张、心肌细胞肥大和收缩功能障碍。APN-KO小鼠的左心室功能受损与心肌细胞肥大、远隔区凋亡活性增加和间质纤维化以及梗死边缘区毛细血管密度降低有关。WT小鼠和APN-KO小鼠之间梗死面积无差异。在WT小鼠中给予腺病毒介导的脂联素导致左心室扩张减少和左心室功能改善,这与梗死边缘区毛细血管密度增加以及远隔区心肌细胞肥大减少、心肌凋亡减少和间质纤维化减少有关。这些数据表明,脂联素通过其抑制心脏肥大和间质纤维化以及防止心肌细胞和毛细血管丢失的能力,保护心肌梗死后收缩功能障碍的发生发展。